Advanced studies of AstraZeneca’s COVID-19 candidate vaccine are temporarily discontinued while the company examines whether a report of a patient with a serious-looking effect is similar to the injection.
In a statement released Tuesday night, the company said its “standard review procedure had caused a pause in vaccination to allow review of protection data. “
AstraZeneca did not disclose any facts about imaginable appearance effects unless she calls it “a potentially unexplained disease. “The STAT news site first reported the pause in testing, stating that the imaginable-looking effect had occurred in the UK.
An AstraZeneca spokesman showed that the vaccination break covers studies in the United States and other countries. Late last month, AstraZeneca began recruiting another 30,000 people in the United States for its largest vaccine study. , in thousands of others in Britain, and in smaller studios in Brazil and South Africa.
Two other vaccines are in the latter stages of major testing in the United States, one manufactured through Moderna Inc. and the other through Pfizer and The German BioNTech. These two vaccine paintings of those of AstraZeneca, and studies have already recruited about two-thirds of the necessary volunteers.
Temporary suspensions of primary medical studies are not unusual, and research into any serious or unforeseen reaction is a mandatory component of protective testing. AstraZeneca is under pressure that the challenge is possibly a coincidence; diseases of all kinds can also occur in studies of thousands of people.
“We are running to speed up the review of the bachelor occasion to minimize any possible effect on the test schedule,” the company said.
The progression came on the same day that AstraZeneca and 8 other drug brands made a commitment, pleding to meet the highest moral and clinical criteria in the progression of their vaccines.
The announcement stems from fears that President Donald Trump will put pressure on the U. S. Food and Drug Administration to pass a vaccine before it becomes effective.
The United States has invested billions of dollars in efforts to expand several vaccines opposed to COVID-19, but public fears that a vaccine is uncertain or useless may simply be disastrous and derail efforts to vaccinate millions of Americans.
FDA officials did not respond to requests for comment Tuesday night.
___
The Associated Press Department of Health and Science is supported by the Department of Scientific Education at Howard Hughes Medical Institute. The AP is for all content only.